ViiV Healthcare gets FDA nod for two-month dosing of Cabenuva to treat HIV

ViiV Healthcare gets FDA nod for two-month dosing of Cabenuva to treat HIV

Submitted by admin on February 2, 2022 - 10:57am
Source: 
Pharmaceutical Business Review
News Tags: 
ViiV Healthcare
FDA
HIV
Cabenuva
Headline: 
ViiV Healthcare gets FDA nod for two-month dosing of Cabenuva to treat HIV
snippet: 

Specialist HIV company ViiV Healthcare has secured the US Food and Drug Administration (FDA) approval for the expanded labelling of Cabenuva (cabotegravir, rilpivirine) to treat HIV-1 in adults.

Do Not Allow Advertisers to Use My Personal information